Europe
Aspen’s offer to cut prices of cancer drugs allows it to avoid EU fine
Brussels — Aspen Pharmacare warded off a possible hefty EU antitrust fine after regulators accepted the pharmaceutical company’s offer to cut cancer drug prices in Europe by about two-thirds, in…

